Ryan Specialty (NYSE:RYAN) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Key Points

• Ryan Specialty beat earnings expectations: Third-quarter EPS was $0.51 versus the $0.49 consensus, while revenue rose 4.7% year over year to approximately $790 million, slightly below analyst estimates.
• Growth remained solid but market conditions worsened: Organic revenue growth was 4%, while management cited declining property prices, increased casualty competition and other pressures that could modestly reduce full-year adjusted EBITDAC margins.
• Management raised its growth outlook and returned capital: The company expects organic revenue growth toward the high end of its mid-single-digit range, repurchased $150 million of shares, and returned $173.7 million to shareholders during the quarter.

Ryan Specialty (NYSE:RYAN - Get Free Report) released its earnings results on Thursday. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.49 by $0.02, FiscalAI reports. The business had revenue of $789.96 million during the quarter, compared to analysts' expectations of $792.99 million. Ryan Specialty had a return on equity of 43.97% and a net margin of 7.55%. During the same quarter last year, the firm posted $0.47 earnings per share.

Here are the key takeaways from Ryan Specialty's conference call:

• Third-quarter results remained resilient: revenue increased 4.7% to $790 million, organic growth was 4%, adjusted EBITDAC rose 3.8% to $244 million, and adjusted EPS grew 8.5% to $0.51 despite a difficult comparison.
• Market conditions are becoming more competitive, with continued property pricing declines, broader casualty competition, new capacity in delegated authority, and softness in builders risk. Management expects further property pricing deterioration in the fourth quarter and into 2027, while full-year adjusted EBITDAC margin is expected to decline modestly.
• Management raised its 2026 outlook for organic revenue growth to the higher end of its mid-single-digit range and cited cost discipline, Empower efficiencies, strong producer retention, and the eventual accretion of its late-2025 hiring class as margin and growth tailwinds.
• Ryan Specialty is expanding AI-related insurance offerings and internal automation, including a $625 million GPU facility and expanded transit coverage of up to $100 million per shipment. The company also repurchased $150 million of shares in the quarter and had $100 million remaining under its authorization.
• Management sees potential for a more active M&A environment in 2027 and continued growth in reinsurance, delegated authority, data-center infrastructure, and other complex specialty risks, supported by strong client demand and the company’s specialty distribution platform.

Ryan Specialty Stock Up 1.3%

RYAN stock traded up $0.57 during trading on Thursday, reaching $43.19. 1,990,006 shares of the stock were exchanged, compared to its average volume of 1,929,863. The firm's 50 day moving average is $40.39 and its 200 day moving average is $39.24. Ryan Specialty has a twelve month low of $29.28 and a twelve month high of $58.94. The company has a current ratio of 1.00, a quick ratio of 1.00 and a debt-to-equity ratio of 3.51. The firm has a market cap of $11.05 billion, a P/E ratio of 20.01, a price-to-earnings-growth ratio of 0.87 and a beta of 0.61.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on RYAN shares. Weiss Ratings raised Ryan Specialty from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, September 18th. Cantor Fitzgerald raised their price objective on shares of Ryan Specialty from $34.00 to $41.00 and gave the stock a "neutral" rating in a research report on Monday, August 3rd. Royal Bank Of Canada lifted their price objective on shares of Ryan Specialty from $45.00 to $55.00 and gave the company an "outperform" rating in a research note on Friday, July 31st. Mizuho dropped their target price on shares of Ryan Specialty from $43.00 to $40.00 and set a "neutral" rating on the stock in a research report on Wednesday, October 7th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Ryan Specialty from $39.00 to $45.00 and gave the company an "underweight" rating in a research report on Monday, August 3rd. Eight equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $52.21.

Ryan Specialty News Roundup

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: Third-quarter adjusted earnings per share were $0.51, exceeding the $0.49 analyst consensus. Revenue rose 4.7% year over year to approximately $790 million, while net income increased 40.6% to $88 million. Ryan Specialty Q3 Adjusted Earnings, Revenue Rise
• Positive Sentiment: Ryan Specialty returned $173.7 million to shareholders during the quarter, including $150 million in stock repurchases and $23.7 million in dividends and distributions. The company also maintained its full-year outlook for mid-single-digit organic revenue growth. Ryan Specialty Q3 Revenue Rises 4.7% to $790 Million
• Neutral Sentiment: Revenue was slightly below the approximately $793 million analyst estimate, making the quarter a mixed result despite the EPS beat. Ryan Specialty earnings results
• Negative Sentiment: Organic revenue growth slowed to 4%, a deceleration that raised concerns about the company’s underlying expansion rate. Management also indicated that the full-year adjusted EBITDAC margin could decline modestly from the prior year. Ryan Specialty organic growth slows to 4% in Q3 earnings beat
• Negative Sentiment: The balance sheet remains highly leveraged, with approximately $3.7 billion of outstanding debt and a debt-to-equity ratio of 3.51. That leverage may limit flexibility if growth or profitability weakens. Ryan Specialty posts mixed Q3 2026 results

About Ryan Specialty

Ryan Specialty Holdings, Inc is a specialty insurance services company that provides wholesale brokerage, managing general underwriting and delegated authority solutions. The company works with retail insurance brokers, agents, carriers and other market participants to place and manage complex, specialty risks that may require specialized underwriting expertise or customized coverage.

Its business includes specialty insurance and reinsurance brokerage, underwriting management and insurance program administration.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.